Iron dysregulation, manifesting as inappropriately low serum hepcidin levels and hyperferritinemia, is common in chronic liver diseases, whereas high level of serum and hepatic hepcidin has been reported in NAFLD since both obesity and diabetes are considered to increase hepcidin production10,11. Here, HAMP is linked to metabolic dysfunction-associated steatotic liver disease.